ARTICLE | Clinical News
Lifitegrast regulatory update
April 13, 2015 7:00 AM UTC
FDA accepted and granted Priority Review to an NDA from Shire for lifitegrast to treat signs and symptoms of dry eye disease in adults. The PDUFA date is Oct. 25. Shire gained lifitegrast -- an eye dr...